Skip to main content
EB

Ebumab

Copenhagen, Denmark
Last funding
$495K
Convertible NoteSep 2022

Ebumab is a biotechnology research company utilizing AMT technology in combination with the body’s own immune system to fight cancer.

About Ebumab

How much funding has Ebumab raised?

Ebumab has raised $495K in total funding. The most recent round was Convertible Note. The last funding was announced in September 2022.

Who are Ebumab's investors?

Ebumab's investors include BioInnovation Institute.

Where is Ebumab headquartered?

Ebumab is headquartered in Copenhagen, Denmark.

What does Ebumab do?

Ebumab is a biotechnology research company utilizing AMT technology in combination with the body’s own immune system to fight cancer.

What stage is Ebumab at?

Ebumab is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Ebumab — Funding & Investors." VCBacked, September 6, 2022, https://www.vcbacked.co/company/ebumab. Accessed November 16, 2026.
APA
VCBacked. (2022). Ebumab — Funding & Investors. Retrieved November 16, 2026, from https://www.vcbacked.co/company/ebumab
Wikipedia (cite web)
{{cite web |title=Ebumab — Funding & Investors |url=https://www.vcbacked.co/company/ebumab |website=VCBacked |access-date=November 16, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Ebumab? Request a listing update

Founder contacts
m***@ebumab.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →